Do Not Stop the Warfarin Until ...

Journal of the American College of Cardiology

Volumn 55, Issue 8, 2010, Pages 744-746

  Cakulev, Ivan ^a   Waldo, Albert L ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

atrial fibrillation; catheter ablation; oral anticoagulation

Indexed keywords

WARFARIN;

ANTICOAGULANT THERAPY; CATHETER ABLATION; CHEMOPROPHYLAXIS; EDITORIAL; HEART ATRIUM FIBRILLATION; INCIDENCE; PRIORITY JOURNAL; SINUS RHYTHM; THROMBOEMBOLISM; TREATMENT WITHDRAWAL;

ANTICOAGULANTS; ATRIAL FIBRILLATION; CATHETER ABLATION; HUMANS; THROMBOEMBOLISM; TREATMENT OUTCOME; WARFARIN;

EID: 76449098096     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.12.008     Document Type: Editorial

References (16)

1. Meiltz A., Zimmermann M., Urban P., and Bloch A. Atrial fibrillation management by practice cardiologists: a prospective survey on the adherence to guidelines in the real world. Europace 10 (2008) 674-680
2. Gage B.F., Waterman A.D., Shannon W., Boechler M., Rich M.W., and Radford M.J. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 285 (2001) 2864-2870
3. Themistoclakis S., Corrado A., Marchlinski F.E., et al. The risk of thromboembolism and need for oral anticoagulation after successful atrial fibrillation ablation. J Am Coll Cardiol 55 (2010) 735-743
4. Calkins H., Brugada J., Packer D.L., et al. HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Heart Rhythm 4 (2007) 816-861
5. Natale A., Raviele A., Arentz T., et al. Venice chart international consensus document on atrial fibrillation ablation. J Cardiovasc Electrophysiol 18 (2007) 560-580
6. Fuster V., Ryden L.E., Cannom D.S., et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). J Am Coll Cardiol 48 (2006) 854-906
7. Pappone C., Rosanio S., Augello G., et al. Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study. J Am Coll Cardiol 42 (2003) 185-197
8. Shah A.N., Mittal S., Sichrovsky T.C., et al. Long-term outcome following successful pulmonary vein isolation: pattern and prediction of very late recurrence. J Cardiovasc Electrophysiol 19 (2008) 661-667
9. Bertaglia E., Tondo C., De Simone A., et al. Does catheter ablation cure atrial fibrillation?. Single-procedure outcome of drug-refractory atrial fibrillation ablation: a 6-year multicentre experience. Europace (2009 Nov 3) [E-pub ahead of print]
10. Sawhney N., Anousheh R., Chen W.C., Narayan S., and Feld G.K. Five-year outcomes after segmental pulmonary vein isolation for paroxysmal atrial fibrillation. Am J Cardiol 104 (2009) 366-372
11. Hindricks G., Piorkowski C., Tanner H., et al. Perception of atrial fibrillation before and after radiofrequency catheter ablation: relevance of asymptomatic arrhythmia recurrence. Circulation 112 (2005) 307-313
12. Martinek M., Aichinger J., Nesser H.J., Ziegler P.D., and Purerfellner H. New insights into long-term follow-up of atrial fibrillation ablation: full disclosure by an implantable pacemaker device. J Cardiovasc Electrophysiol 18 (2007) 818-823
13. Gage B.F., van Walraven C., Pearce L., et al. Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin. Circulation 110 (2004) 2287-2292
14. Go A.S., Hylek E.M., Chang Y., et al. Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?. JAMA 290 (2003) 2685-2692
15. Singer D.E., Chang Y., Fang M.C., et al. The net clinical benefit of warfarin anticoagulation in atrial fibrillation. Ann Intern Med 151 (2009) 297-305
16. Halperin J.L. Ximelagatran compared with warfarin for prevention of thromboembolism in patients with nonvalvular atrial fibrillation: rationale, objectives, and design of a pair of clinical studies and baseline patient characteristics (SPORTIF III and V). Am Heart J 146 (2003) 431-438